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Abstract
To determine the association between attention-deficit hyperactivity disorder （ADHD） and 
nocturnal enuresis （NE） and its relation to the effectiveness of NE treatment in children 
undiagnosed with developmental disorders.  A total of 154 children with NE （112 males and 
42 females） were included in this study, aged ≥ 5–＜15 years, presenting at the Department of 
Pediatrics, Showa University Fujigaoka Hospital, between January 2016 and June 2017.  None 
of the participants was diagnosed with developmental disorders.  We retrospectively evaluated 
Attention-Deficit Hyperactivity Disorder Rating Scale-IV （ADHD-RS-IV） scores, Dysfunctional 
Voiding Symptom Score （DVSS）, NE clinical characteristics, and efficacy of NE treatment.  The 
mean age was 8.0±2.0 years （standard deviation）.  Sixty-seven （40.3％） patients presented 
with daytime incontinence （DI）.  The mean total ADHD-RS and DVSS scores were 7.7±
8.0 and 6.6±4.3, respectively, and they were significantly correlated （p＝0.049）.  ADHD-
RS scores were significantly higher in patients with DI than in those without DI （p＝0.0006）.  
ADHD-RS scores and large-volume DI （a DVSS subscale item） were significantly correlated.  
Six months after treatment initiation, patients with ＜50％ improvement （nonresponder） 
in NE had significantly higher total ADHD-RS scores than those with ≥ 50％ improvement 
（responder） （p＝0.007）.  Even in patients not diagnosed with developmental disorders, ADHD 
characteristics may influence the clinical course of NE.  Evaluation of ADHD characteristics 
using a screening tool such as the ADHD-RS is important in the NE treatment.
Key words :  enuresis, urinary incontinence, attention-deficit hyperactivity disorder, lower urinary 
tract symptoms
Introduction
　Nocturnal enuresis （NE） results from various 
factors, such as polyuria, abnormal urine storage 
mechanisms, and sleeping disorders1 ; however, recent 
findings have established a relationship between NE 
and developmental disorders1-5.
　Attention-deficit hyperactivity disorder （ADHD） 
is a developmental disorder characterized by 
hyperactivity, impulsiveness, and inattentiveness.  
　Previously, a correlation between NE and ADHD 
was found （odds ratio, 2.88 ; 95％ confidence interval ; 
1.26-6.57）6, and children with NE and ADHD are 
more likely to complain of daytime incontinence 
（DI）7.  Compliance with lifestyle modifications for 
NE and DI can be difficult in patients with ADHD, 
and treatment for ADHD may be needed prior to 
NE and DI treatments.  Therefore, understanding 
and considering ADHD characteristics in therapeutic 
and educational NE and DI treatments are clinically 
important.  However, identifying ADHD characteristics 
during NE and DI treatments is not always easy.
　The ADHD Rating Scale-IV （ADHD-RS-IV） is 
one of the most widely utilized screening measures 
for ADHD characteristics8.  Several studies have 
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reported the relationship between ADHD and 
NE and DI9, 10.  However, the correlation between 
ADHD-RS scores and NE and DI in children not 
diagnosed with developmental disorders has not been 
fully explored.  Therefore, we assessed the ADHD-
RS scores, Dysfunctional Voiding Symptom Score 
（DVSS）11, which is an index of lower urinary tract 
symptoms （LUTS）, NE clinical characteristics, and 
responsiveness to NE treatment in children with NE 
not diagnosed with developmental disorders.  
Materials and methods
Target Population
　The potential participants were 176 patients, aged 
≥ 5–＜15 years, who visited the Department of 
Pediatrics, Showa University Fujigaoka Hospital, Japan, 
between January 2016 and June 2017, presenting with 
NE.  Eighteen patients diagnosed with developmental 
disabilities by a psychiatrist in other hospitals and 
four patients with concomitant underlying diseases 
（meningocele, n＝1 ; urethral strictures, n＝2 ; bladder 
diverticulum, n＝1） were excluded.  A final total of 
154 patients were included.  
Methods
　We conducted a retrospective study to determine 
the correlations among ADHD-RS scores, DVSS, NE 
clinical characteristics, and efficacy of NE treatment 
using the patients’ medical records.  At the first visit, 
the patients’ statuses were recorded by their families 
for the last month on the ADHD-RS and DVSS 
questionnaires.  
　ADHD-RS is a tool used for ADHD screening, 
diagnosis, and treatment evaluation, consisting of 18 
questions that measure hyperactivity, impulsiveness, 
and inattentiveness8.  Each question assesses the 
frequency of behavior on a scale of 0-3 （0, never 
or rarely ; 1, sometimes ; 2, often ; 3, very often）; 
the higher the score, the greater the symptom 
impairment8.  
　The DVSS questionnaire11 was developed by 
the Hospital for Sick Children, affiliated with the 
University of Toronto, to evaluate LUTS, such as DI, 
volume of urine leakage, and urinary frequency in 
children11.  It is comprised of seven LUTS and two 
bowel symptoms questions scored on a scale of 0-3 
（0, almost never ; 1, less than half the time ; 2, about 
half the time ; and 3, almost every time）.
　In this study, the Japanese versions of ADHD-RS 
（Figure 1） and DVSS （Figure 2） were utilized.
　The patients and their parents were informed 
about NE treatments including pharmacotherapy 
（desmopressin, orally disintegrating tablets） and alarm 
therapy after initial 4-12-week behavioral therapies, 
such as water restriction, to choose one of them. 
In the case of choosing pharmacotherapy, 120 µg 
of desmopressin was given daily for 2-4 weeks ; 
partial responders were maintained on the same 
dose, whereas an increased dose of 240 µg daily was 
administered to the nonresponders, based on the 
Fig. 1.  Attention-Deficit Hyperactivity Disorder Rating Scale-IV （ADHD-RS-IV）.
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number of wet nights.  Initial nonresponders who 
achieved a complete response （CR） for ≥ 4 weeks 
during the treatment at the higher dose had their 
dose reduced to 120 µg, whereas in patients with a 
maintained CR with ≥ 4 additional weeks at the 120 µg 
dose, the dose was further lowered to 120 µg on 
alternate days for 8 weeks.
Definitions
　NE : Nocturnal enuresis, one or more episodes of 
nighttime incontinence per month lasting for at least 
3 months.
　DI : Daytime incontinence for at least 1 day per 
month lasting for at least 3 months.
　Constipation : Fewer than three bowel movements 
（defecation） per week.
　CR : Complete response, urine leakage completely 
resolving or decreasing to less than once a month.
　PR : Partial response, the number of days of urine 
leakage decreased by ≥ 50％.
　NR : Nonresponse, the number of days of urine 
leakage decreased by ＜50％.
Ethical Standards
　This study was approved by the Ethics Committee 
of Showa University Fujigaoka Hospital （permit 
number : F2019C67） and was conducted following 
the principles of the Declaration of Helsinki 1964. 
Informed consent was obtained from all the parents 
prior to enrolling their children.
Statistical Analyses
　Data analysis was conducted using JMPⓇ Pro 
version 10.0 （SAS Institute Inc., Cary, NC, USA）. 
Numerical variables （age, ADHD-RS score, and 
DVSS score） were presented as means and standard 
deviations and were compared using Wilcoxon’s rank-
sum test.  Categorical variables （sex, DI, PR, and 
NR） were presented as counts and percentages and 




　The study population included 154 patients （112 
［72.3％］ boys and 42 ［27.3％］ girls ; mean age
± standard deviation 7.97±1.96 years）.  Sixty-two 
patients （40.3％） complained of DI, 11 （7.1％） of 
constipation, and 17 （11.0％） of fecal incontinence. 
The average wet nights per week at the first visit was 
5.16 ± 2.29, and the median follow-up duration was 12 
months.
DVSS Total and Subscale Scores 
　The mean total DVSS was 6.63±4.24.  There 
were no significant sex differences in total DVSS （p
＝0.693）; however, older age was associated with 
significantly lower total DVSS （p＜0.0001）.  There 
was no significant relationship between total DVSS 
and average wet nights per week at the first visit （p
＝0.118）.
　Means and standard deviations for the DVSS 
subscale scores were as follows : incontinence during 
the day, 0.97±1.26 ; large-volume DI, 0.98±1.25 ; low-
frequency urination, 0.82±0.85 ; urinary urgency, 1.55
±1.06 ; urination posture, 1.10±1.12 ; painful urination, 
0.05±0.21 ; dysuria, 0.16±0.55 ; the interval between 
bowel movements, 0.34±0.65 ; dyschezia, 0.64±0.90.
Fig. 2.  Dysfunctional Voiding Symptom Score （DVSS）.




　The means and standard deviations for total 
ADHD-RS scores were 7.67±8.00 （hyperactivity and 
impulsivity scores : 2.82±3.34 ; inattention scores : 4.84
±5.16）.  No significant sex differences were observed 
（p＝0.734）.  Hyperactivity and impulsivity scores 
significantly decreased with age （p＝0.018）; however, 
inattention and total ADHD-RS scores were not 
significantly correlated with age （p＝0.678 and 0.471, 
resp.）.  Patients with DI had significantly higher total 
ADHD-RS scores than those without DI （p＝0.006） 
（Figure 3）.  There was no significant correlation 
between the average wet nights per week at the first 
visit and total ADHD-RS scores （p＝0.535）.
Correlation Between DVSS and ADHD-RS Scores
 There were significant positive correlations between 
the total DVSS and ADHD-RS hyperactivity and 
impulsivity subscale scores （p＝0.037） and total 
ADHD-RS score （p＝0.049） （Figure 4）.  Table 1 
demonstrates the correlations between ADHD-
RS and DVSS individual subscale scores.  ADHD-
RS hyperactivity and impulsiveness scores were 
significantly correlated with incontinence during the 
day （p＝0.0096）, large-volume DI （p＝0.0078）, low-
frequency urination （1-2 times per day） （p＝0.0484）, 
and dysuria （p＝0.0233）.  Total ADHD-RS and 
ADHD-RS inattentiveness scores were related only 
to large-volume DI （p＝0.0149 ; p＝0.0425, resp.） 
（Figure 5）.
Correlation Between the Efficacy of NE Treatment and 
ADHD-RS Scores
　After initiating treatment, 110 out of 154 patients 
were followed up for ＞6 months ; the treatment 
effect at 6 months was CR in 15 （13.6％）, PR in 
59 （53.6％）, and NR in 36 （32.7％） patients.  There 
were no significant sex differences.  The mean time 
from treatment initiation to CR in children with NE 
was 19.4±15.0 months, and there were no medication 
side-effects.
　A comparison of ADHD-RS scores between the 
response （PR and CR） and nonresponse （NR） 
groups was carried out to examine the relationship 
Fig. 3.   Correlation between Attention-Deficit Hyperactivity Disorder Rating Scale-IV 
（ADHD-RS-IV） scores and DI.
Fig. 4.   Correlation between Attention-Deficit Hyperactivity Disorder Rating Scale-IV 
（ADHD-RS-IV） scores and Dysfunctional Voiding Symptom Score （DVSS）.
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Fig. 6.   Correlations between the efficacy of nocturnal enuresis （NE） treatment 
and Attention-Deficit Hyperactivity Disorder Rating Scale-IV （ADHD-RS-IV） 
scores at the first visit.
NR group : nonresponse group, NE decreased by ＜ 50％ from the initial visit.
R group : response group （PR or CR）, NE decreased by ≥ 50％ from the initial visit.
Fig. 5.   Correlations between Attention-Deficit Hyperactivity Disorder Rating Scale-
IV （ADHD-RS-IV） scores and large-volume daytime incontinence （DVSS 
subscale） scores.
Table 1.   The relationship between Attention-Deficit Hyperactivity Disorder Rating Scale-IV 
（ADHD-RS-IV） and Dysfunctional Voiding Symptom Score （DVSS） （p value）
ADHD-RS
Hyperactivity and 
impulsivity Inattention Total score
Total DVSS 0.0371 0.0914 0.0486
DVSS subscales
Number of DI days 0.0096 0.1795 0.0505
Large-volume DI 0.0078 0.0425 0.0149
Low-frequency urination 0.0484 0.5306 0.2176
Urinary urgency 0.2418 0.3595 0.2773
Urination posture 0.1399 0.2358 0.1646
Painful urination 0.1561 0.0501 0.0619
Dysuria 0.0233 0.1334 0.0540
Intervals between bowel movements 0.7512 0.7347 0.9310
Dyschezia 0.8058 0.7585 0.7620
DI : daytime incontinence.
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between the efficacy of NE treatment and ADHD-RS 
scores.  It indicated that all ADHD-RS scores at the 
first visit were higher in the nonresponse group than 
those in the response group （Figure 6）.  
Discussion
　NE prevalence differs according to the region and 
studies : 15％-20％ at the age of 5 years ; 5％-10％ 
at 7 years ; 5％ at 10 years ; 1％-3％ at 15 years1, 12-14. 
About 15％-40％ of children with NE had LUTS-
related complications15, 16 ; however, the reported 
incidence of these complications is as high as 50％- 
80％17. 
　ADHD is  a  developmental  disorder and 
characterized by hyperactive, impulsive, and 
inattentive18 behaviors, affecting 3％-5％ of children19. 
The symptoms are 3-4 times more common in boys 
than in girls, and inattentiveness becomes increasingly 
evident with age.  Furthermore, NE and DI are 2.7 
and 4.5 times more common, respectively, in children 
with ADHD than in healthy children.
　DVSS were significantly higher for children with 
ADHD than for healthy children20-22 ; therefore, 
assessing ADHD characteristics and LUTS is highly 
important in children with NE.  In this study, there 
is a significant correlation between higher ADHD-
RS scores and higher DVSS even in children with 
NE not diagnosed with ADHD, similar to previous 
findings for children with ADHD20-22.  
　High ADHD-RS scores only indicate the presence 
of hyperactivity and inattention characteristics. 
However, to diagnose ADHD, clear evidence that 
these symptoms interfere with or reduce the quality 
of social functioning is required23.  Although children 
with high ADHD-RS scores may exhibit similar 
characteristics to those in children with ADHD, the 
diagnosis of ADHD is only established in some 
children with high ADHD-RS scores.  Further studies 
are warranted to assess the differences between NE 
characteristics with ADHD and NE characteristics 
with high ADHD-RS scores only.
　Yang et al. analyzed DVSS subscale scores 
of NE children with and without ADHD.  The 
ADHD group had significantly higher urinary 
urgency （cannot wait） and low-frequency urination 
（urinating 1-2 times/day） scores than the non-
ADHD group20.  In contrast, in this study, ADHD-
RS hyperactivity and impulsivity scores were 
significantly correlated with DVSS subscale scores, 
including incontinence during the day, large-volume 
DI, and low-frequency urination （1-2 times daily）, 
whereas urinary urgency was not correlated with 
total ADHD-RS, hyperactivity, impulsivity, and 
inattention scores.  The pathologies for NE and DI 
in ADHD include impaired urinary signal sensing 
from the bladder owing to decreased frontal-striatal 
responses, voiding urgency due to overconcentration 
caused by dopaminergic nervous system dysfunction, 
and inadequate capacity to respond to the timing 
of voiding because of behavioral factors such as 
hyperactivity and inattention7, 21.  In this study, more 
pronounced ADHD hyperactivity and impulsivity 
symptoms were related to higher volume for each 
urinary incontinence episode and lower urination 
frequency.  Therefore, urinary incontinence in these 
children was associated with poor awareness of the 
need to void and delayed timing of voiding, rather 
than urge incontinence due to bladder overactivity. 
The outcomes of this study are different from those 
of previous studies revealing that children with 
ADHD experience a high urgency.  However, urgency 
assessment in children is challenging ; thus, this should 
be thoroughly investigated in the future.  
　ADHD treatment may improve NE and DI, and 
evaluating ADHD characteristics in children with 
NE and DI is of critical importance4.  However, 
it  is  challenging for physicians, other than 
child psychiatrists, to objectively assess ADHD 
characteristics, even if ADHD is suspected during NE 
and DI treatments.  Particularly, since hyperactivity 
and impulsivity become less noticeable and inattention 
becomes prevalent with age, evaluating inattention 
within the timeframe of examinations is of a great 
challenge.  Hyperactivity, impulsivity, and inattention 
can be easily evaluated using the ADHD-RS, and the 
collected information may be beneficial for applying 
lifestyle modifications.  Besides, this tool is a useful 
index enabling families to request recommendations 
for medical examinations from specialists.  ADHD-
RS was originally developed to screen ADHD and 
evaluate therapeutic effectiveness ; however, ADHD 
cannot be solely diagnosed using this tool ; thus 
assessments conducted by a child psychiatrist are 
required.  Once ADHD has been diagnosed by 
a psychiatrist, pharmacotherapy and psychosocial 
treatments will make lifestyle guidance for NE 
and DI more effective.  Additionally, assessment 
of ADHD characteristics is useful in tailoring an 
NE treatment based on the child’s developmental 
characteristics.  In children with ADHD characteristics, 
cognition of voiding frequency as a visual event 
and setting attainable goals are critical.  If a child 
cannot systematically go to the toilet, using methods 
such as periodic voiding alarms could be considered. 
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Moreover, improving a child’s self-esteem and 
promoting the continuation of NE and DI treatments 
are highly improtant.
　The presence of ADHD complications in children 
with NE does not influence the therapeutic effects of 
pharmacotherapy, such as the use of desmopressin20, 22. 
However, in this study, children with NR had 
significantly higher ADHD-RS scores than those 
with PR or CR 6 months after treatment initiation. 
Although compliance with lifestyle guidance and 
pharmacotherapy might have influenced the study’s 
results, these factors were not evaluated.  Therefore, 
further investigation is required.  
　This study had some limitations as follows.  Ideally, 
the ADHD-RS should be administered in two 
settings : at school and at home ; however, the tool 
was employed only in the home setting.  Therefore, 
families may have underestimated or overestimated 
the children’s restlessness and inattention.  Sex, age, 
and racial differences in ADHD-RS scores have been 
considered.  Generally, inattentiveness, rather than 
hyperactivity or impulsivity, is more prevalent in older 
children and girls, presenting statistical limitations for 
the analyses.  In this study, DVSS and ADHD-RS 
scores were evaluated only at the first visit.  Thus, 
consecutive assessments of the scores and long-term 
evaluation of the associations between DVSS and 
ADHD-RS scores and therapeutic effects are still 
needed.  Autism spectrum disorder may have an 
effect on NE and DI ; however, herein, this aspect 
was not considered.  This study was conducted at 
a university hospital and included several children 
who were referred because of poor responses to 
standard therapy, resulting in patients’ background 
characteristics bias.
　This study identified a correlation between DVSS 
and ADHD-RS scores and demonstrated that 
ADHD-RS scores were higher in children whose 
NE decreased by ＜50％ than in children whose 
NE decreased by ≥ 50％.  Therefore, in the clinical 
management of NE, assessing the developmental 
characteristics and LUTS is essential for children 
not diagnosed with developmental disorders.  Using 
screening tools, such as ADHD-RS, facilitates the 
evaluation of developmental characteristics, even 
for general pediatricians who are not specialists in 
psychiatry, leading to a more effective NE treatment.
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